CPRX vs. MO

Last updated Jul 21, 2026

CPRX (Catalyst Pharmaceuticals, Inc.) and MO (Altria Group, Inc.) are both stocks. CPRX operates in Biotechnology (Healthcare), while MO operates in Tobacco (Consumer Defensive). Over the past 10 years, CPRX returned 44.91%/yr vs 7.92%/yr for MO. At a 0.10 correlation, their price movements are largely independent.

Performance

CPRX vs. MO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Catalyst Pharmaceuticals, Inc. (CPRX) and Altria Group, Inc. (MO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both stocks are quite close, with CPRX having a 34.92% return and MO slightly lower at 33.62%. Over the past 10 years, CPRX has outperformed MO with an annualized return of 44.91%, while MO has yielded a comparatively lower 7.92% annualized return.

CPRX

• 1D: 0.00%
• 1M: 0.35%
• 6M: 38.72%
• YTD: 34.92%
• 1Y: 49.74%
• 3Y*: 32.72%
• 5Y*: 41.46%
• 10Y*: 44.91%
• ALL TIME*: 8.79%

MO

• 1D: 0.61%
• 1M: 8.02%
• 6M: 24.75%
• YTD: 33.62%
• 1Y: 37.41%
• 3Y*: 27.19%
• 5Y*: 18.35%
• 10Y*: 7.92%
• ALL TIME*: 18.00%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CPRX vs. MO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CPRX Catalyst Pharmaceuticals, Inc.	34.92%	11.84%	24.15%	-9.62%	174.74%	102.69%	-10.93%	95.31%	-50.90%	272.38%
MO Altria Group, Inc.	33.62%	18.17%	40.76%	-3.70%	4.37%	24.18%	-10.21%	7.87%	-27.14%	9.45%

Correlation

The correlation between CPRX and MO is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.09
Correlation (5Y) Calculated over the trailing 5-year period	0.10
Correlation (10Y) Calculated over the trailing 10-year period	0.11
Correlation (All Time) Calculated using the full available price history since Nov 8, 2006	0.10

Fundamentals

Market Cap CPRX : $3.85B MO : $124.67B
EPS CPRX : $1.74 MO : $4.80
PE Ratio CPRX : 18.08 MO : 15.56
PEG Ratio CPRX : 0.32 MO : 0.33
PS Ratio CPRX : 6.70 MO : 5.74
Total Revenue (TTM) CPRX : $596.96M MO : $21.82B
Gross Profit (TTM) CPRX : $378.23M MO : $14.80B
EBITDA (TTM) CPRX : $313.50M MO : $11.70B

Return for Risk

CPRX vs. MO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CPRX

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

MO

MO Risk / Return Rank: 84
MO Sharpe Ratio Rank: 87
MO Sortino Ratio Rank: 83
MO Omega Ratio Rank: 84
MO Calmar Ratio Rank: 82
MO Martin Ratio Rank: 82

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CPRX vs. MO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Altria Group, Inc. (MO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CPRX	MO	Difference
Sharpe ratio: Return per unit of total volatility	1.54	1.62	-0.08
Sortino ratio: Return per unit of downside risk	2.14	2.18	-0.04
Omega ratio: Gain probability vs. loss probability	1.31	1.30	+0.01
Calmar ratio: Return relative to maximum drawdown	3.52	2.29	+1.23
Martin ratio: Return relative to average drawdown	9.42	5.75	+3.68

CPRX vs. MO - Sharpe Ratio Comparison

The current CPRX Sharpe Ratio is 1.54, which is comparable to the MO Sharpe Ratio of 1.62. The chart below compares the historical Sharpe Ratios of CPRX and MO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CPRX vs. MO - Drawdown Comparison

The maximum CPRX drawdown since its inception was -94.25%, which is greater than MO's maximum drawdown of -65.43%. Use the drawdown chart below to compare losses from any high point for CPRX and MO.

Drawdown Indicators

	CPRX	MO	Difference
Max Drawdown Largest peak-to-trough decline	-94.25%	-65.43%	-28.82%
Max Drawdown (1Y) Largest decline over 1 year	-13.91%	-16.40%	+2.49%
Max Drawdown (3Y) Largest decline over 3 years	-27.29%	-16.40%	-10.89%
Max Drawdown (5Y) Largest decline over 5 years	-45.37%	-25.83%	-19.54%
Max Drawdown (10Y) Largest decline over 10 years	-64.87%	-53.69%	-11.18%
Current Drawdown Current decline from peak	-0.03%	0.00%	-0.03%
Average Drawdown Average peak-to-trough decline	-51.73%	-11.91%	-39.82%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.18%	6.53%	-1.35%

Volatility

CPRX vs. MO - Volatility Comparison

The current volatility for Catalyst Pharmaceuticals, Inc. (CPRX) is 0.41%, while Altria Group, Inc. (MO) has a volatility of 7.16%. This indicates that CPRX experiences smaller price fluctuations and is considered to be less risky than MO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CPRX	MO	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.41%	7.16%	-6.75%
Volatility (6M) Calculated over the trailing 6-month period	21.80%	18.14%	+3.66%
Volatility (1Y) Calculated over the trailing 1-year period	31.77%	23.27%	+8.50%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	47.65%	20.82%	+26.83%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	59.86%	23.09%	+36.77%

Dividends

CPRX vs. MO - Dividend Comparison

CPRX has not paid dividends to shareholders, while MO's dividend yield for the trailing twelve months is around 5.68%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CPRX Catalyst Pharmaceuticals, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
MO Altria Group, Inc.	5.68%	7.21%	7.65%	9.52%	8.05%	7.43%	8.29%	6.57%	6.07%	3.56%	3.48%	3.73%

Financials

CPRX vs. MO - Profitability Comparison

The chart below illustrates the profitability comparison between Catalyst Pharmaceuticals, Inc. and Altria Group, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Portfolio components

CPRX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Catalyst Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 149.39M. Therefore, the gross margin over that period was 0.0%.

MO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Altria Group, Inc. reported a gross profit of 3.51B and revenue of 5.43B. Therefore, the gross margin over that period was 64.6%.

CPRX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Catalyst Pharmaceuticals, Inc. reported an operating income of 73.23M and revenue of 149.39M, resulting in an operating margin of 49.0%.

MO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Altria Group, Inc. reported an operating income of 2.96B and revenue of 5.43B, resulting in an operating margin of 54.5%.

CPRX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Catalyst Pharmaceuticals, Inc. reported a net income of 63.73M and revenue of 149.39M, resulting in a net margin of 42.7%.

MO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Altria Group, Inc. reported a net income of 2.18B and revenue of 5.43B, resulting in a net margin of 40.2%.

Frequently Asked Questions

Can I hold both CPRX and MO in my portfolio?

CPRX and MO have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CPRX or MO?

MO has higher volatility (7.16%) compared to CPRX (0.41%). In terms of maximum drawdown, CPRX dropped -94.25% vs MO's -65.43%.

Which has better risk-adjusted returns?

MO currently has the higher Sharpe Ratio (1.62 vs 1.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.